Phase I study of immuno-Cell therapy for advanced and recurrent esophageal squamous cell carcinoma
Not Applicable
- Conditions
- Advanced and recurrent esophageal squamous cell carcinoma
- Registration Number
- JPRN-UMIN000007841
- Lead Sponsor
- Toho University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1.patient who has severe complication 2.patient who has bleeding tendency 3.patient who has active infectious disease 4.concomitant treatment with steroids 5.HBs antigen, HCV antibody, HIV antibody or HTLV-1 antibody is positive 6.patient who has activated autoimmune disease 7.patient who was judged to be unsuitable for this clinical trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety and responsibility
- Secondary Outcome Measures
Name Time Method